Evidence map›Paper›PMID 28234358›Full record

ArticleCell death and differentiation2017

AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression.

Xiaofei Sun, Qiyuan Yang, Carl J Rogers, Min Du, Mei-Jun Zhu

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 229 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. 4-Methylesculetin improves the growth performance of grass carp (Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Macronutrients as Regulators of Intestinal Epithelial Permeability: Where Do We Stand?Comprehensive reviews in food science and food safety · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Observational
  16. Frontiers in cellular and infection microbiology · 2025
    Article
  17. Article
  18. Article
  19. Frontiers in immunology · 2025
    Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xiaofei SunSchool of Food Science, Washington State University, Pullman 99164, WA, USA.
Qiyuan YangDepartment of Animal Science, Washington State University, Pullman 99164, WA, USA.
Carl J RogersDepartment of Animal Science, Washington State University, Pullman 99164, WA, USA.
Min DuDepartment of Animal Science, Washington State University, Pullman 99164, WA, USA.
Mei-Jun ZhuSchool of Food Science, Washington State University, Pullman 99164, WA, USA.
Washington State University · USUniversity of Idaho · US

Funding

Maternal Obesity, AMPK and Development of Fetal and Neonatal GutR15HD073864 · NICHD · UNIVERSITY OF WYOMING · PI ZHU, MEIJUN · 2012 to 2012
$412k
NICHD NIH HHS R15 HD073864
6 · The paper itself

Abstract

Impairment in gut epithelial integrity and barrier function is associated with many diseases. The homeostasis of intestinal barrier is based on a delicate regulation of epithelial proliferation and differentiation. AMP-activated protein kinase (AMPK) is a master regulator of energy metabolism, and cellular metabolites are intrinsically involved in epigenetic modifications governing cell differentiation. We aimed to evaluate the regulatory role of AMPK on intestinal epithelial development and barrier function. In this study, AMPK activator (AICAR) improved the barrier function of Caco-2 cells as indicated by increased transepithelial electrical resistance and reduced paracellular FITC-dextran permeability; consistently, AICAR enhanced epithelial differentiation and tight junction formation. Transfection of Caco-2 cells with AMPK WT plasmid, which enhances AMPK activity, improved epithelial barrier function and epithelial differentiation, while K45R (AMPK dominant negative mutant) impaired; these changes were correlated with the expression of caudal type homeobox 2 (CDX2), the key transcription factor committing cells to intestinal epithelial lineage. CDX2 deficiency abolished intestinal differentiation promoted by AMPK activation. Mechanistically, AMPK inactivation was associated with polycomb repressive complex 2 regulated enrichment of H3K27me3, the inhibitory histone modification, and lysine-specific histone demethylase-1-mediated reduction of H3K4me3, a permissive histone modification. Those histone modifications provide a mechanistic link between AMPK and CDX2 expression. Consistently, epithelial AMPK knockout in vivo reduced CDX2 expression, impaired intestinal barrier function, integrity and ultrastructure of tight junction, and epithelial cell migration, promoted intestinal proliferation and exaggerated dextran sulfate sodium-induced colitis. In summary, AMPK enhances intestinal barrier function and epithelial differentiation via promoting CDX2 expression, which is partially mediated by altered histone modifications in the Cdx2 promoter.

Indexed as

Aminoimidazole CarboxamideAMP-Activated Protein KinasesAnimalsCaco-2 CellsCDX2 Transcription FactorCell DifferentiationColitisColonDextransEpithelial CellsFluorescein-5-isothiocyanateGene Expression RegulationHistone DemethylasesHistonesHumansIntestinal MucosaAICA ribonucleotideAminoimidazole CarboxamideAMP-Activated Protein KinasesCDX2 protein, humanCDX2 Transcription FactorDextransFluorescein-5-isothiocyanatefluorescein isothiocyanate dextranHistone DemethylasesHistonesKDM1A protein, humanPolycomb Repressive Complex 2RibonucleotidesSodium Dodecyl Sulfate

Identifiers

PMID28234358
PMCPMC5423107
OpenAlexW2590624416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.